Skip to main content
Research use only (RUO) — laboratory and qualified research programs only
BLU

Tirzepatide research peptide procurement brief: dual incretin identity and CoA review

8 min read · Research use only

Written and reviewed by BluGen Research Team · Editorial standards

This procurement brief helps laboratory purchasing and QA teams evaluate Tirzepatide as research-use-only material: what identity fields to confirm, what a valid lot CoA must include, how to handle receiving, and which documentation red flags should stop inventory acceptance. It is not medical, dosing, or consumer guidance.

Identity fields to confirm before accepting the lot

Tirzepatide is a dual GIP/GLP-1 receptor analogue. Identity review must confirm the dual-agonist sequence/modification and MW—not Semaglutide (single GLP-1) or Retatrutide (triple agonist).

Match SKU, lot number, and CoA document ID before opening the outer carton. Photograph labels when your chain-of-custody SOP requires it.

What a valid CoA must show

Lot CoA should include HPLC purity, MS identity, and net peptide content. Keep Tirzepatide documentation separate from other incretin SKUs even when ordered in the same PO.

Prefer suppliers that also allow public lot verification. BluGen lots can be checked in the CoA Library when published for that batch.

Handle as a lipidated lyophilized research peptide: cold, dry, light-protected; aliquot after reconstitution. Do not copy Semaglutide buffers or free-fraction assumptions without verification.

Use net peptide content for molarity calculations. Gross vial mass systematically overstates active peptide when water and counter-ions are present.

Documentation red flags

Any of the following should trigger quarantine pending supplier clarification:

  • Treating Tirzepatide as “stronger Semaglutide” in protocol design
  • Shared CoA packet with a different incretin SKU
  • Missing MS confirmation of the lipidated species
  • Unclear lot traceability on multi-SKU shipments

Next steps

Open the Tirzepatide product page for SKU variants and identity tables, then read the matching research guide and any related comparison article before finalizing the PO.

Pair this brief with the supplier evaluation checklist, CoA reading guide, and reconstitution calculator for a complete receiving package.

Frequently asked questions

Is this Tirzepatide brief for clinical purchasing?

No. All materials discussed are research use only and are not for human or veterinary administration, diagnosis, or treatment.

What is the minimum CoA package for this SKU?

Lot-specific HPLC purity, MS identity matching the expected form, and net peptide content when concentration work is required—plus a clear lot number on vial and document.

Where do I verify a BluGen lot?

Use the public CoA Library lot lookup when the lot is published, and retain the shipment CoA in your LIMS or procurement file.

Citation

BluGen Research Peptides — Tirzepatide research peptide procurement brief: dual incretin identity and CoA review. https://getblugen.com/research/tirzepatide-research-peptide-procurement-brief/. Accessed 2026-08-14.

Products referenced in this guide

Browse all Metabolic →

Related research

Checkout